Join to View Full Profile
Division of Hematology/Oncology, UC Irvine Med Center101 The City Dr SouthOrange, CA 92868
Phone+1 714-456-5153
Fax+1 714-456-2242
Dr. Zell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jason Zell is an oncologist in Orange, CA and is affiliated with UCI Medical Center. He received his medical degree from Nova Southeastern University - College of Osteopathic Medicine and has been in practice 16 years. He specializes in gastrointestinal cancer and hematologic oncology and is experienced in hematologic oncology, clinical research, gastrointestinal oncology, and clinical trials.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2003 - 2007- University of California (Irvine)Residency, Internal Medicine, 2001 - 2003
Nova Southeastern University College of Osteopathic MedicineClass of 2001
Certifications & Licensure
CA State License 2002 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Physician of Excellence Orange County Medical Association, 2014-2023
- Super Doctors, Rising Star - Los Angeles www.superdoctors.com
- Cancer Clinical Investigator Team Leadership Award National Institutes of Health, National Cancer Institute
- Join now to see all
Clinical Trials
- Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Start of enrollment: 2007 Jun 01
- Trial of Aspirin and Arginine Restriction in Colorectal Cancer Start of enrollment: 2008 Sep 24
- Erlotinib Hydrochloride in Treating Patients With Stage I-III Colorectal Cancer or Adenoma Start of enrollment: 2008 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Estimated True Out-of-Pocket Cost Changes From the Inflation Reduction Act on Medicare Part D Beneficiaries With Cancer.Aryana Sepassi, Nico Gabriel, Sean D Sullivan, A Mark Fendrick, Jason A Zell
Value in Health. 2025-07-15 - Assessing preventive gynecologic decisions in individuals with Lynch syndrome.Rebecca M Waggoner, Ryan P Mahoney, Deepika Nathan, Jason A Zell, Julie O Culver
Gynecologic Oncology. 2025-06-01 - Disparities of Distant Metastasis Evaluation Imaging for Rectal Cancer.Brittany Le, Angelina Lo, Wen-Pin Chen, Gelareh Sadigh, Jason Zell
Journal of the American College of Radiology. 2025-05-15
Books/Book Chapters
Press Mentions
Decades-Long Standard of Care in Head and Neck Cancer Set to Change?June 3rd, 2025
Beating Cancer – One Patient at a TimeFebruary 23rd, 2020
University of California (Irvine) Hematology Oncology FellowshipMay 5th, 2017- Join now to see all
Grant Support
- Advancing novel cancer preventive and therapeutic strategies across the modern NCI clinical trial networksUNIVERSITY OF CALIFORNIA-IRVINE2024–2029
- Risk Reduction Through Polyamine Inhibition Among Colorectal Carcinoma PatientsNational Cancer Institute2009–2011
- Phase IIA Clinical Biomarker Trial Of Aspirin And Arginine Restriction In ColonNational Center For Research Resources2010
Committees
- Chair, The Hope Foundation/Dr. Charles Coltman Fellowship Award Committee 2013 - Present
- Section Editor, Gastrointestinal Oncology, Editorial Board, Journal of Adolescent and Young Adult Oncology 2010 - Present
- Associate Editor, Editorial Board, Journal of Carcinogenesis 2010 - 2013
Professional Memberships
- Member
- Member
- Member
- Member
External Links
- Clinical Profilehttp://www.ucirvinehealth.org/find-a-doctor/z/jason-zell/
- Academic Profilehttp://www.faculty.uci.edu//profile.cfm?faculty_id=5483
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
